HomeDCPXF • OTCMKTS
add
DanCann Pharma A/S
Market news
Financials
Income Statement
Revenue
Net income
| (DKK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.62M | -12.78% |
Operating expense | 1.63M | 0.68% |
Net income | -1.56M | 45.29% |
Net profit margin | -96.54 | 37.28% |
Earnings per share | — | — |
EBITDA | -1.04M | -15.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (DKK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 498.00K | 147.76% |
Total assets | 12.80M | -18.57% |
Total liabilities | 5.73M | 138.32% |
Total equity | 7.06M | — |
Shares outstanding | 3.99M | — |
Price to book | 0.01 | — |
Return on assets | -29.30% | — |
Return on capital | -48.43% | — |
Cash Flow
Net change in cash
| (DKK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.56M | 45.29% |
Cash from operations | -1.11M | -40.68% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.11M | -119.31% |
Free cash flow | 1.08M | 115.16% |
About
Founded
2018
Website
Employees
5
